Rothkamm K - Search Results

1

Targeted nanoparticles for tumour radiotherapy enhancement-the long dawn of a golden era?

Gargioni E, Schulz F, Raabe A, Burdak-Rothkamm S, Rieckmann T, Rothkamm K. Gargioni E, et al. Among authors: rothkamm k. Ann Transl Med. 2016 Dec;4(24):523. doi: 10.21037/atm.2016.12.46. Ann Transl Med. 2016. PMID: 28151534 Free PMC article.

2

ATM acts downstream of ATR in the DNA damage response signaling of bystander cells.

Burdak-Rothkamm S, Rothkamm K, Prise KM. Burdak-Rothkamm S, et al. Among authors: rothkamm k. Cancer Res. 2008 Sep 1;68(17):7059-65. doi: 10.1158/0008-5472.CAN-08-0545. Cancer Res. 2008. PMID: 18757420 Free PMC article.

3

Cohesin promotes the repair of ionizing radiation-induced DNA double-strand breaks in replicated chromatin.

Bauerschmidt C, Arrichiello C, Burdak-Rothkamm S, Woodcock M, Hill MA, Stevens DL, Rothkamm K. Bauerschmidt C, et al. Among authors: rothkamm k. Nucleic Acids Res. 2010 Jan;38(2):477-87. doi: 10.1093/nar/gkp976. Epub 2009 Nov 11. Nucleic Acids Res. 2010. PMID: 19906707 Free PMC article.

4

Ionizing radiation-induced DNA strand breaks and γ-H2AXγ-H2AX foci in cells exposed to nitric oxide.

Rothkamm K, Burdak-Rothkamm S. Rothkamm K, et al. Methods Mol Biol. 2011;704:17-25. doi: 10.1007/978-1-61737-964-2_2. Methods Mol Biol. 2011. PMID: 21161626

5

BRCA1, FANCD2 and Chk1 are potential molecular targets for the modulation of a radiation-induced DNA damage response in bystander cells.

Burdak-Rothkamm S, Rothkamm K, McClelland K, Al Rashid ST, Prise KM. Burdak-Rothkamm S, et al. Among authors: rothkamm k. Cancer Lett. 2015 Jan 28;356(2 Pt B):454-61. doi: 10.1016/j.canlet.2014.09.043. Epub 2014 Oct 7. Cancer Lett. 2015. PMID: 25304378 Free PMC article.

6

DNA damage foci: Meaning and significance.

Rothkamm K, Barnard S, Moquet J, Ellender M, Rana Z, Burdak-Rothkamm S. Rothkamm K, et al. Environ Mol Mutagen. 2015 Jul;56(6):491-504. doi: 10.1002/em.21944. Epub 2015 Mar 12. Environ Mol Mutagen. 2015. PMID: 25773265 Review.

7

EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells.

Struve N, Riedel M, Schulte A, Rieckmann T, Grob TJ, Gal A, Rothkamm K, Lamszus K, Petersen C, Dikomey E, Kriegs M. Struve N, et al. Among authors: rothkamm k. Oncotarget. 2015 Oct 20;6(32):33867-77. doi: 10.18632/oncotarget.5293. Oncotarget. 2015. PMID: 26418954 Free PMC article.

8

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells.

Möckelmann N, Rieckmann T, Busch CJ, Becker B, Gleißner L, Hoffer K, Omniczynski M, Steinmeister L, Laban S, Grénman R, Petersen C, Rothkamm K, Dikomey E, Knecht R, Kriegs M. Möckelmann N, et al. Among authors: rothkamm k. Oncotarget. 2016 Apr 26;7(17):23542-51. doi: 10.18632/oncotarget.8275. Oncotarget. 2016. PMID: 27015558 Free PMC article.

9

Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines.

Busch CJ, Becker B, Kriegs M, Gatzemeier F, Krüger K, Möckelmann N, Fritz G, Petersen C, Knecht R, Rothkamm K, Rieckmann T. Busch CJ, et al. Among authors: rothkamm k. Oncotarget. 2016 Jun 14;7(24):35832-35842. doi: 10.18632/oncotarget.9028. Oncotarget. 2016. PMID: 27127883 Free PMC article.

10

Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests.

Kriegs M, Kasten-Pisula U, Riepen B, Hoffer K, Struve N, Myllynen L, Braig F, Binder M, Rieckmann T, Grénman R, Petersen C, Dikomey E, Rothkamm K. Kriegs M, et al. Among authors: rothkamm k. Oncotarget. 2016 Jul 19;7(29):45122-45133. doi: 10.18632/oncotarget.9161. Oncotarget. 2016. PMID: 27281611 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters